Published in
Taylor and Francis Group, Acta Oncologica, 7(61), p. 869-873, 2022
DOI: 10.1080/0284186x.2022.2079959
Links
Tools
Precision radiation of immune checkpoint therapy resistant melanoma metastases (PROMMEL study): study protocol for a phase II open-label multicenter trial
Journal article published in 2022 by
Ellen Backlund,
Muyi Yang,
Vitali Grozman,
Giuseppe Masucci 
,
Johan Falkenius,
Hanna Eriksson,
Braslav Jovanovic,
Katarina Hammarlund,
Ulf Isacsson,
Calin Radu,
Edvard Abel,
Kristin Karlsson,
Ricardo Palanco Zamora,
Peter Wersäll,
Ulrika Edbäck
and other authors.
,
Johan Falkenius,
Hanna Eriksson,
Braslav Jovanovic,
Katarina Hammarlund,
Ulf Isacsson,
Calin Radu,
Edvard Abel,
Kristin Karlsson,
Ricardo Palanco Zamora,
Peter Wersäll,
Ulrika Edbäck
and other authors.
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 